Treatment of primate islets with anti-class II antibodies and complement fails to deplete class II-bearing cells.
Flynn
G J
GJ
Nuffield Department of Surgery, J. Radcliffe Hospital, University of Oxford, England.
Leow
C K
CK
Sutton
R S
RS
Gray
D W
DW
Morris
P J
PJ
D000911:Antibodies, Monoclonal / Q000276:immunology*; D000936:Antigen-Antibody Complex; D002469:Cell Separation / Q000379:methods; D016650:Fluorescein-5-isothiocyanate; D005452:Fluoresceins; D005456:Fluorescent Dyes; D006684:HLA-DR Antigens / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006801:Humans; D007515:Islets of Langerhans / Q000166:cytology / Q000276:immunology*; D013861:Thiocyanates
D000911:Antibodies, Monoclonal; D000936:Antigen-Antibody Complex; D005452:Fluoresceins; D005456:Fluorescent Dyes; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D013861:Thiocyanates; D016650:Fluorescein-5-isothiocyanate